A questionnaire-based survey on depression and anxiety among rheumatology patients during the covid-19 pandemic: Patient’s perspective

A questionnaire-based survey on depression and anxiety among rheumatology patients during the covid-19 pandemic: Patient’s perspective

Objectives: The Coronavirus Disease 2019 (COVID-19) outbreak is a global pandemic and has caught the attention of the rheumatology fraternity, where patients are thought to be at higher risk of infection. We aimed to study the incidence of COVID-19 infection and depression and anxiety symptoms among...

Full description

Bibliographic Details
Main Authors: Baharuddin, H. (Author), Bhullar, A. (Author), Ch’ng, S.S (Author), Lim, S.L (Author), Rosman, A. (Author), Tay, V.Y (Author), Yusoof, H.M (Author), Zain, M.M (Author)
Format: Article
Language:English
Published: Oman Medical Specialty Board 2021
Series:Oman Medical Journal
Subjects:
adalimumab
adolescent
adult
aged
anxiety
Anxiety
Article
azathioprine
belimumab
comorbidity
coronavirus disease 2019
corticosteroid
COVID-19
COVID-19 testing
Cross-Sectional Studies
cross-sectional study
cyclophosphamide
cyclosporine
depression
Depression
etanercept
female
filgotinib
Generalized Anxiety Disorder-2
golimumab
human
hydroxychloroquine
incidence
infliximab
ixekizumab
leflunomide
major clinical study
Malaysia
male
methotrexate
mycophenolate mofetil
pandemic
Patient Health Questionnaire
Patient Health Questionnaire 2
prednisolone
rheumatic disease
Rheumatic Diseases
rheumatoid arthritis
Rheumatology
rituximab
salazosulfapyridine
secukinumab
spondyloarthropathy
structured questionnaire
systemic lupus erythematosus
tacrolimus
tocilizumab
tofacitinib
ustekinumab
Online Access:View Fulltext in Publisher
View in Scopus

Internet

View Fulltext in Publisher
View in Scopus

Similar Items